Published in J Burn Care Rehabil on February 22, 2000
The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant (2008) 1.39
Analysis of N-(4-hydroxyphenyl)retinamide polymorphic forms by X-ray powder diffraction. J Pharm Sci (1984) 1.38
Emerging approaches to the tissue engineering of fat. Clin Plast Surg (1999) 1.35
Decellularized human valve allografts. Ann Thorac Surg (2001) 1.18
Lumbar synovial cysts eroding bone. AJNR Am J Neuroradiol (1992) 1.07
Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors. Transplantation (1986) 1.06
Composite tissue (hand) allotransplantation: are we ready? Plast Reconstr Surg (2001) 1.06
Vascularized bone marrow transplantation (VBMT): induction of stable mixed T-cell chimerism and transplantation tolerance in unmodified recipients. Transplant Proc (1991) 1.03
Long-term skin allograft survival after short-term cyclosporin treatment in a patient with massive burns. Lancet (1986) 0.98
BioGlue surgical adhesive for thoracic aortic repair during coagulopathy: efficacy and histopathology. Ann Thorac Surg (2001) 0.93
The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg (1999) 0.92
Transcutaneous PO2 in flaps: a new method of survival prediction. Plast Reconstr Surg (1980) 0.90
Metabolic syndrome in adolescents in the Balearic Islands, a Mediterranean region. Nutr Metab Cardiovasc Dis (2010) 0.89
Transpecies heart valve transplant: advanced studies of a bioengineered xeno-autograft. Ann Thorac Surg (2000) 0.88
Cyclosporine and skin allografts for the treatment of thermal injury. II. Development of an experimental massive third-degree burn model demonstrating extensive graft survival. Transplantation (1988) 0.87
Computer-assisted anthropometry for outcome assessment of cleft lip. Plast Reconstr Surg (1999) 0.87
Recellularization of heart valve grafts by a process of adaptive remodeling. Semin Thorac Cardiovasc Surg (2001) 0.84
Beneficial effects of cyclosporine and rapamycin in small bowel ischemic injury. J Surg Res (1996) 0.84
Chemotherapeutic treatment of malignant chordoma in children. J Pediatr Hematol Oncol (1996) 0.83
The pKa of butaclamol and the mode of butaclamol binding to central dopamine receptors. J Med Chem (1985) 0.83
Cosmas and Damian in the laboratory. N Engl J Med (1982) 0.82
Burn depth evaluation with fluorometry: is it really definitive? J Burn Care Rehabil (1987) 0.81
A pair of five-day flaps: early division of distant pedicles after serial cross-clamping and observation with oximetry and fluorometry. Ann Plast Surg (1985) 0.81
Intracellular calcium buffering declines in aging adrenergic nerves. Neurobiol Aging (1997) 0.81
Transformation of nonvascular acellular tissue matrices into durable vascular conduits. Ann Thorac Surg (2001) 0.81
A method of endoscopic endotracheal intubation in rabbits. Lab Anim (2001) 0.80
Aneurysm of the azygos pericallosal artery: diagnosis by MR imaging and MR angiography. AJNR Am J Neuroradiol (1992) 0.80
Vascularized composite tissue mandibular transplantation in dogs. Transplant Proc (1997) 0.80
Impact of age on modulation of norepinephrine release from sympathetic nerves in the rat superior mesentery artery. Life Sci (1998) 0.79
Site-specific suppression of cell-mediated immunity by cyclosporine. J Invest Dermatol (1990) 0.79
Kinetics of intravenous theophylline. Clin Pharmacol Ther (1977) 0.79
A rapid and sensitive cellular enzyme-linked immunoabsorbent assay (CELISA) for the detection and quantitation of antibodies against cell surface determinants. I. A comparison of cell fixation and storage techniques. J Immunol Methods (1992) 0.79
The effects of testicular trauma on fertility in the Lewis rat and comparisons to isoimmunized recipients of syngeneic sperm. J Urol (1990) 0.79
Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation. Transplant Proc (1995) 0.79
An in vivo evaluation of a chondroitin sulfate solution to prevent postoperative intraperitoneal adhesion formation. J Surg Res (2000) 0.78
Development of haloperidol in oil injection formulations. J Parenter Sci Technol (1985) 0.78
Hemorrhagic subependymal giant cell astrocytoma. Pediatr Radiol (1995) 0.78
Partial tolerance in rat renal allograft recipients following multiple blood transfusions and concomitant cyclosporine. Transplantation (1990) 0.78
A comparison of hemostatic agents in microvascular surgery. J Microsurg (1982) 0.78
Postoperative abdominal wall defects with enterocutaneous fistulae. Am J Surg (1996) 0.78
Exogenous surfactant treatment before and after sixteen hours of ischemia in experimental lung transplantation. J Thorac Cardiovasc Surg (1997) 0.78
A simple method for the isolation of platelet-free lymphocyte suspensions from rat whole blood. J Immunol Methods (1980) 0.77
Composite tissue allografts in rats: IV. Graft-versus-host disease in recipients of vascularized bone marrow transplants. Plast Reconstr Surg (1999) 0.77
Second International Symposium on Composite Tissue Allotransplantation. Introduction. Microsurgery (2000) 0.77
Transcutaneous oxygen and flaps. Plast Reconstr Surg (1984) 0.77
Composite tissue (limb) allografts in rats. II. Indefinite survival using low-dose cyclosporine. Transplantation (1985) 0.77
The effect of cyclosporine in gut ischemic injury: a computerized morphometric and enzymatic analysis. J Pediatr Surg (1996) 0.77
Endothelin-1 potentiates the in vitro contractile response of pregnant human myometrium to oxytocin. Am J Obstet Gynecol (1995) 0.77
The effect of leukocyte infiltration on apoptosis in an in vitro thermal injury bioartificial living skin equivalent model. J Burn Care Rehabil (1999) 0.77
Comparative studies of FK506 with cyclosporine. Transplantation (1988) 0.77
Transcutaneous PO2 monitoring of flap circulation following surgery. Birth Defects Orig Artic Ser (1979) 0.77
A novel device for the simple and efficient refinement of liposuctioned tissue. Plast Reconstr Surg (2001) 0.76
Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts. Transplantation (1990) 0.76
Composite tissue (limb) allografts in rats. I. Dose-dependent increase in survival with cyclosporine. Transplantation (1985) 0.76
In vitro bioartificial skin culture model of tissue rejection and inflammatory/immune mechanisms. Transplant Proc (1997) 0.76
Vanishing bile duct syndrome after liver transplantation: alloreactivity or viral reactivity? Transplant Proc (1995) 0.76
Overview of a 10-year experience on methods and compositions for inducing site-specific immunosuppression with topical immunosuppressants. Transplant Proc (1996) 0.76
Vascularized bone marrow transplantation: A new surgical approach using isolated femoral bone/bone marrow. J Surg Res (2000) 0.76
Past, present, and future research in the field of composite tissue allotransplantation. Microsurgery (2000) 0.76
Preoperative chemotherapy-sensitized radiation therapy for cervical metastases in head and neck cancer. Arch Otolaryngol Head Neck Surg (2000) 0.76
Enhanced kidney graft survival in rats by single or multiple blood transfusion(s) and various blood products. Transplant Proc (1982) 0.76
Two new composite tissue allograft models in rats to study neuromuscular functional return. Transplant Proc (1987) 0.76
Evaluation of the lumbar spine in patients with glycogen storage disease: CT demonstration of patterns of paraspinal muscle atrophy. AJNR Am J Neuroradiol (1992) 0.75
Lymphocyte chimerism in a full allogeneic composite tissue (rat-limb) allograft model prolonged with cyclosporine. Transplant Proc (1988) 0.75
Immunocytes of composite tissue allografts express elevated levels of TGF beta mRNA and protein during chronic rejection. Transplant Proc (1997) 0.75
A novel technique in a sheep model for evaluating prosthetic heart valve performance. J Invest Surg (2001) 0.75
A rapid and sensitive cellular enzyme-linked immunoabsorbent assay (CELISA) for the detection and quantitation of antibodies against cell surface determinants. II. Optimal reagent concentrations and predictive analysis. Cell Transplant (1997) 0.75
Neonatal bone fragments for the induction of xenograft acceptance: transplantation of xenogeneic hematopoietic stem cells and species-specific microenvironment for hematopoiesis. Transplant Proc (1997) 0.75
Digital image analysis of major histocompatibility complex class I and class II expression during site-specific immune suppression with topical cyclosporine. Transplant Proc (1995) 0.75
Revascularization of the upper extremity in a preterm infant: a case report and review of the literature. Ann Plast Surg (1999) 0.75
Multicystic, heterogeneously enhancing meningioma in an octogenerian. Br J Neurosurg (2004) 0.75
Quantitative facial motion analysis after functional free muscle reanimation procedures. Plast Reconstr Surg (1997) 0.75
Mechanisms of unresponsiveness associated with pretransplant blood transfusion-cyclosporine-induced mixed lymphocyte chimerism. Transpl Int (1994) 0.75
Fascial release as an adjunct to wound closure. Br J Plast Surg (1996) 0.75
Use of regression analysis and flow cytometry for determining levels of mixed semiallogeneic immune chimerism. J Invest Surg (1997) 0.75
Graft-versus-host disease in limb transplantation: digital image analysis of bone marrow and TGF-beta expression in situ using a novel 3-D microscope. Transplant Proc (1996) 0.75
Spleen mixed leukocyte chimerism and induction of tolerance in rat renal allograft recipients conditioned with donor-specific blood transfusions and cyclosporine. Transplant Proc (1995) 0.75
Quantitation of an orally available thrombin inhibitor in rat, monkey and human plasma and in human urine by high-performance liquid chromatography and fluorescent post-column derivatization of arginine. J Chromatogr A (1997) 0.75
Transmyocardial laser revascularization: current status. J Invest Surg (2000) 0.75
Mechanisms of site-specific immunosuppression. Transplant Proc (1991) 0.75